Inventor · disambiguated record
Christian F. Wertz
Also filed as: WERTZ CHRISTIAN F
23 granted patents·16 pending applications·114 citations·filing 2003–2024
95Inventor score
Files withNANOCOPOEIA LLC18ELAN PHARMA INT LTD7HANDA THERAPEUTICS LLC3UPSHER SMITH LAB INC3WERTZ CHRISTIAN F3
Top patents by PatentIndex Score
39 records- 0196US11413290B2Amorphous solid dispersions of dasatinib and uses thereofNANOCOPOEIA LLC·Filed 2021·Granted Aug 16, 2022·8 cites·30 claims
- 0296US11324745B2Amorphous solid dispersions of dasatinib and uses thereofNANOCOPOEIA LLC·Filed 2021·Granted May 10, 2022·7 cites·30 claims
- 0396US11298356B1Amorphous solid dispersions of dasatinib and uses thereofNANOCOPOEIA LLC·Filed 2021·Granted Apr 12, 2022·7 cites·30 claims
- 0496US11202778B2Amorphous solid dispersions of dasatinib and uses thereofNANOCOPOEIA LLC·Filed 2021·Granted Dec 21, 2021·9 cites·30 claims
- 0595US11633398B2Amorphous solid dispersions of dasatinib and uses thereofNANOCOPOEIA LLC·Filed 2022·Granted Apr 25, 2023·2 cites·28 claims
- 0695US11389450B2Amorphous nilotinib microparticles and uses thereofNANOCOPOEIA LLC·Filed 2021·Granted Jul 19, 2022·7 cites·28 claims
- 0794US11980619B2Pharmaceutical compositions and crushable tablets including amorphous solid dispersions of dasatinib and usesNANOCOPOEIA LLC·Filed 2022·Granted May 14, 2024·3 cites·18 claims
- 0892US7459283B2Nanoparticulate compositions having lysozyme as a surface stabilizerELAN PHARMA INT LTD·Filed 2003·Granted Dec 2, 2008·38 cites·57 claims
- 0989US11559485B2Orally disintegrating tablet comprising amorphous solid dispersion of nilotinibNANOCOPOEIA LLC·Filed 2021·Granted Jan 24, 2023·6 cites·30 claims
- 1087US8362029B2Opioid-containing oral pharmaceutical compositions and methodsUPSHER SMITH LAB INC·Filed 2009·Granted Jan 29, 2013·10 cites·26 claims
- 1187US8003127B2Nanoparticulate corticosteroid and antihistamine formulations methods of making, and methods of administering thereofELAN PHARMA INT LTD·Filed 2006·Granted Aug 23, 2011·10 cites·24 claims
- 1285US2025032491A1Amorphous nilotinib microparticles and uses thereofNANOCOPOEIA LLC·Filed 2024·Application pending·0 cites
- 1382US12053471B2Amorphous nilotinib microparticles and uses thereofNANOCOPOEIA LLC·Filed 2023·Granted Aug 6, 2024·0 cites·22 claims
- 1482US12016861B2Amorphous nilotinib microparticles and uses thereofNANOCOPOEIA LLC·Filed 2022·Granted Jun 25, 2024·0 cites·22 claims
- 1582US11998548B2Amorphous nilotinib microparticles and uses thereofNANOCOPOEIA LLC·Filed 2022·Granted Jun 4, 2024·0 cites·19 claims
- 1681US12465606B2Amorphous solid dispersions of dasatinib and uses thereofHANDA THERAPEUTICS LLC·Filed 2022·Granted Nov 11, 2025·0 cites·20 claims
- 1781US12433891B2Amorphous solid dispersions of dasatinib and uses thereofHANDA THERAPEUTICS LLC·Filed 2022·Granted Oct 7, 2025·0 cites·20 claims
- 1880US12029740B2Amorphous nilotinib microparticles and uses thereofNANOCOPOEIA LLC·Filed 2022·Granted Jul 9, 2024·0 cites·24 claims
- 1979US12478625B2Pharmaceutical compositions and crushable tablets including amorphous solid dispersions of dasatinib and usesHANDA THERAPEUTICS LLC·Filed 2024·Granted Nov 25, 2025·0 cites·17 claims
- 2079US2022105035A1Amorphous solid dispersions of dasatinib and uses thereofNANOCOPOEIA LLC·Filed 2021·Application pending·0 cites
- 2177US9023390B2Sustained-release product comprising a combination of a non-opioid amine and a non-steroidal anti-inflammatory drugWERTZ CHRISTIAN F·Filed 2009·Granted May 5, 2015·4 cites·17 claims
- 2275US9456985B2Sustained-released product comprising a combination of a non-opioid amine and a non-steroidal, anti-inflammatory drugUPSHER-SMITH LABORATORIES INC·Filed 2015·Granted Oct 4, 2016·2 cites·19 claims
- 2373US8323641B2Nanoparticulate compositions having lysozyme as a surface stabilizerWERTZ CHRISTIAN F·Filed 2008·Granted Dec 4, 2012·1 cites·23 claims
- 2470US2023372325A1Amorphous cabozantinib particles and uses thereofNANOCOPOEIA LLC·Filed 2023·Application pending·0 cites
- 2570US2008152585A1Low viscosity liquid dosage formsELAN PHARMA INT LTD·Filed 2007·Application pending·0 cites
- 2669US2025025463A1Orally disintegrating tablet comprising amorphous solid dispersion of nilotinib and in vitro characterization thereofNANOCOPOEIA LLC·Filed 2024·Application pending·0 cites
- 2764US8987291B2Opioid-containing oral pharmaceutical compositions and methodsUPSHER SMITH LAB INC·Filed 2012·Granted Mar 24, 2015·0 cites·20 claims
- 2864US2023157948A1Orally disintegrating tablet comprising amorphous solid dispersion of nilotinibNANOCOPOEIA LLC·Filed 2023·Application pending·0 cites
- 2963US2013251805A1Low viscosity liquid dosage formsALKERMES PHARMA IRELAND LTD·Filed 2012·Application pending·0 cites
- 3062US2022378788A1Orally disintegrating tablet comprising amorphous solid dispersion of nilotinib and in vitro characterization thereofNANOCOPOEIA LLC·Filed 2022·Application pending·0 cites
- 3161US2004105889A1Low viscosity liquid dosage formsELAN PHARMA INT LTD·Filed 2003·Application pending·0 cites
- 3260US2014234225A1Method of treatment using nanoparticulate compositions having lysozyme as a surface stabilizerALKERMES PHARMA IRELAND LTD·Filed 2014·Application pending·0 cites
- 3355US8652464B2Method of treatment using nanoparticulate compositions having lysozyme as a surface stabilizerALKERMES PHARMA IRLAND LTD·Filed 2012·Granted Feb 18, 2014·0 cites·21 claims
- 3454US2015182462A1Opioid-Containing Oral Pharmaceutical Compositions and MethodsUPSHER SMITH LAB INC·Filed 2015·Application pending·0 cites
- 3553US2004101566A1Novel benzoyl peroxide compositionsELAN PHARMA INT LTD·Filed 2003·Application pending·0 cites
- 3651US2004156872A1Novel nimesulide compositionsELAN PHARMA INT LTD·Filed 2003·Application pending·0 cites
- 3750US2010221328A1Sustained-release formulationsWERTZ CHRISTIAN F·Filed 2009·Application pending·0 cites
- 3845US2012063996A1Novel nimesulide compositionsBOSCH H WILLIAM·Filed 2011·Application pending·0 cites
- 3944US2007065374A1Nanoparticulate leukotriene receptor antagonist/corticosteroid formulationsELAN PHARMA INT LTD·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christian F. Wertz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →